Efficacy of tocalizumab monotherapy in rheumatoid arthritis

Trial Profile

Efficacy of tocalizumab monotherapy in rheumatoid arthritis

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Nov 2011

At a glance

  • Drugs Tocilizumab (Primary) ; Adalimumab; Infliximab; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms T-BONE
  • Most Recent Events

    • 23 Nov 2011 New trial record
    • 09 Nov 2011 Primary endpoint 'Femoral-neck-bone-mineral-density' has been met according to results presented at the ARH/ARHP.
    • 09 Nov 2011 Primary endpoint 'Lumbar-spine-bone-mineral-density' has been met according to results presented at the ARH/ARHP.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top